Similar articles

• [A double-blind study of alizapride in nausea and emesis induced by cancer chemotherapeutic agents (author's transl)].

  Viala JJ, Girard D, Cordier JF. Viala JJ, et al. Sem Hop. 1982 Feb 11;58(6):371-4. Sem Hop. 1982. PMID: 6280306 French. No abstract available.
• A study evaluating the efficacy and tolerability of tropisetron in combination with dexamethasone in the prevention of delayed platinum-induced nausea and emesis.

  Sorbe BG, Berglind AM, Andersson H, Boman K, Högberg T, Hallgren M, Schmidt M. Sorbe BG, et al. Cancer. 1998 Sep 1;83(5):1022-32. Cancer. 1998. PMID: 9731907 Clinical Trial.
• [Evaluation of a new antiemetic, alizapride, in cancerology (author's transl)].

  Cupissol D, Favier F, Favier C, Serrou B. Cupissol D, et al. Sem Hop. 1982 Jun 3;58(22):1370-3. Sem Hop. 1982. PMID: 6287597 French.
• Preventing chemotherapy-induced nausea and vomiting: an update and a review of emesis.

  Ettinger DS. Ettinger DS. Semin Oncol. 1995 Aug;22(4 Suppl 10):6-18. Semin Oncol. 1995. PMID: 7570053 Review. No abstract available.
• [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].

  Jordan K, Voigt W, Schmoll HJ. Jordan K, et al. Dtsch Med Wochenschr. 2006 Aug 25;131(34-35):1869-72. doi: 10.1055/s-2006-949172. Dtsch Med Wochenschr. 2006. PMID: 16915549 Review. German.